Bioxytran Inc (BIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 537 | 819 | 936 | 547 | 1,042 |
| Operating Income | -537 | -819 | -936 | -547 | -1,042 |
| Interest Expense | 55 | 52 | 33 | 33 | 84 |
| Other Income | -42 | -92 | -30 | -30 | -17 |
| Pre-tax Income | -634 | -963 | -998 | -610 | -1,144 |
| Net Income Continuous | -634 | -963 | -998 | -610 | -1,144 |
| Minority Interests | -12 | -51 | 40 | -135 | -247 |
| Net Income | $-622 | $-912 | $-1,038 | $-475 | $-897 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EBITDA(a) | $-495 | $-727 | $-906 | $-517 | $-1,042 |